Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Clinical trial NCT01202903 · COMPLETED
Trial details
- NCT number
- NCT01202903
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-10-01
- Enrollment
- 616
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.